Rights and permissions
About this article
Cite this article
Caspofungin shows efficacy in patients with invasive aspergillosis who are immunocompromised. Inpharma Wkly. 1258, 9 (2000). https://doi.org/10.2165/00128413-200012580-00017
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200012580-00017